Instalab

24h Avg Blood Pressure (Systolic) Test

The most accurate read on your true heart and stroke risk, beyond a single office reading.

Should you take a 24h Avg Blood Pressure (Systolic) test?

This test is most useful if any of these apply to you.

Told Your Blood Pressure Is Borderline
If your office readings hover around 130 to 140, this test reveals whether your real-world pressure is higher, lower, or wildly variable.
Managing Kidney Disease or Diabetes
Your risk of kidney progression and heart events is driven more by your 24-hour average than by any single clinic reading, especially at night.
Already Taking Blood Pressure Medication
Ambulatory monitoring shows whether your treatment is working through the night and the morning surge, not just when you show up to the clinic.
Healthy but Want to Stay Ahead
A baseline 24-hour reading in your 30s or 40s gives you your own trajectory to track, catching a slow rise years before it becomes a diagnosis.

About 24h Avg Blood Pressure (Systolic)

One visit to the doctor cannot tell you what your blood pressure actually does for the other 23 hours and 45 minutes of your day. A wearable cuff that measures you every 15 to 30 minutes while you work, walk, eat, and sleep can. That full-day picture is what predicts heart attacks, strokes, kidney damage, and death better than any single reading.

The 24-hour average systolic blood pressure is the top number (the force when your heart pumps) averaged across a full day and night of automatic readings from ambulatory blood pressure monitoring (ABPM). It catches problems a clinic reading can miss, including pressure that looks fine in the office but is quietly elevated at home or overnight.

What This Number Actually Reflects

Blood pressure is the force your blood exerts on artery walls. Systolic pressure is the higher number, measured the instant your heart contracts. It is shaped by how much blood your heart pumps with each beat, how stiff your arteries have become, how tight or relaxed your small blood vessels are, and how your kidneys balance salt and water. No single organ produces this number. It reflects the combined work of your heart, vessels, nerves, kidneys, and hormones across a full day and night.

Because it is an average of many readings over day and night, it smooths out the noise of a single measurement. That matters because a clinic reading can be artificially high from the stress of being at a doctor's office (white-coat effect) or artificially reassuring in someone whose pressure spikes outside the clinic (masked hypertension).

Heart Attack and Stroke Risk

A 24-hour average systolic reading is one of the strongest predictors of future cardiovascular events, and it often outperforms a clinic reading for this purpose. In an observational study of 59,124 adults in primary care followed for a median of 9.7 years, each standard deviation increase in 24-hour systolic blood pressure was associated with a 41 percent higher risk of all-cause death (HR 1.41, 95% CI 1.36 to 1.47). That risk held up even after adjusting for clinic blood pressure, meaning the ambulatory reading carried information the clinic number did not.

A pooled analysis of 11,135 adults from Europe, Asia, and South America followed for a median of 13.8 years found that for every 20 mmHg rise in 24-hour systolic, the composite risk of cardiovascular events was about 45 percent higher (HR 1.45, 95% CI 1.37 to 1.54), and overall death risk was 22 percent higher (HR 1.22, 95% CI 1.16 to 1.28). The pattern of risk rises continuously, even below classic hypertension thresholds.

Masked hypertension (normal office, elevated 24-hour average) carries roughly the same heart attack and stroke risk as sustained, diagnosed hypertension. You cannot find it without a wearable monitor.

Kidney Disease Progression

In 387 adults with chronic kidney disease, each 1 mmHg increase in 24-hour systolic pressure raised the combined risk of kidney failure or death by 3 percent (HR 1.03, 95% CI 1.01 to 1.04). People with 24-hour readings above 130/80 mmHg had almost five times the risk compared to those under 125/75 mmHg (HR 4.79, 95% CI 1.68 to 13.70). Office readings, in the same study, did not predict outcomes after adjustment. This is a striking finding. The wearable detected real kidney risk the clinic could not.

Cognitive Function and Dementia

Extremes at both ends appear to harm the brain. Frequent hypotensive episodes during 24-hour monitoring (systolic drops below 90 to 100 mmHg) were linked to worse cognitive function and faster decline in processing speed among 842 older adults in the SPRINT study. High day-to-day swings in pressure were also associated with higher risk of probable dementia in trial participants. A stable, moderate 24-hour average is what the brain seems to want.

Nighttime Pressure Tells Its Own Story

Your blood pressure should drop during sleep. A flat or rising night pattern (non-dipping or reverse-dipping) is associated with higher risk independent of the 24-hour average. In 238 young adults with cryptogenic ischemic stroke (stroke without an obvious cause), non-dipping patterns were linked to the stroke in those without a patent foramen ovale. A clinic reading cannot see this because it only captures one moment in the day.

Research-Based Reference Ranges

These tiers come from outcome-based analyses of large multi-ethnic cohorts, mostly from European and Asian populations. They are brachial (upper-arm) ambulatory readings in mmHg. Your lab or monitor report may use slightly different cutpoints, and newer European guidelines target even lower values. Compare your results using the same device and methodology over time.

Tier24-Hour Systolic (mmHg)What It Suggests
Optimal~115Lowest long-term cardiovascular risk
Normal~125Still low risk, mild elevation
Elevated~125 to 130Risk rising; pattern worth investigating
Ambulatory hypertension130 or higherClearly increased cardiovascular risk

Source: Kikuya et al. 2007 (Circulation); Cheng et al. 2019 (Hypertension). Outcome-driven thresholds from the IDACO international database. Newer 2024 European Society of Cardiology criteria define non-elevated 24-hour systolic as below 115 mmHg.

Very low readings are not automatically better. In the Ohasama study in Japan, the best prognosis clustered between 120 and 133 mmHg; risk rose above 134 and also at values below 119 mmHg. If you are older or on multiple medications, chronically low 24-hour pressure can carry its own risks, especially for falls and cognition.

Why One Reading Is Not Enough

Blood pressure is not a single number, it is a moving pattern. Cold exposure can shift systolic by 5 to 32 mmHg. A full bladder can raise it by 4 to 33 mmHg. Acute alcohol, caffeine, and smoking each shift readings by double digits. Even a recent meal or the white-coat effect can shift the number by more than 10 mmHg. A proper 24-hour study averages these fluctuations into a stable, trustworthy picture.

Serial tracking is more valuable than any single test. Get a baseline study. If you are starting or changing a medication, or making meaningful lifestyle changes, retest in 3 to 6 months to see whether the intervention is actually moving your 24-hour average, not just your clinic number. After that, at least annual monitoring gives you a real trajectory. A gradual year-over-year climb is the kind of early signal that lets you act years before you cross a diagnostic threshold.

When Results Can Be Misleading

A single 24-hour study can still be distorted by factors that have nothing to do with your long-term cardiovascular health:

  • Acute illness or pain: fever, infection, or recent injury can push readings higher than your usual baseline
  • Recent stimulants: caffeine within hours of a reading can raise systolic by 3 to 14 mmHg; nicotine can raise it by up to 25 mmHg
  • Cold or full bladder during measurements: both can inflate individual readings by 15 to 30 mmHg or more
  • Acetaminophen and NSAIDs: regular daily acetaminophen use can raise 24-hour systolic by about 5 mmHg, and nonsteroidal anti-inflammatory drugs (NSAIDs) can raise it by 2.8 to 3.9 mmHg, without reflecting your underlying vascular health
  • Perioperative period: pressure is unstable for days to weeks around surgery; readings from this window should not be treated as your baseline

What To Do If Your Result Is Abnormal

A high 24-hour average is a signal to act, not a diagnosis to fear. The first step is to repeat the study under stable conditions to confirm the pattern. If confirmed, pair it with basic labs to look for downstream damage and reversible causes: kidney function (creatinine, cystatin C, urine albumin-to-creatinine ratio), metabolic markers (glucose, HbA1c, lipids), and inflammation (hs-CRP). A non-dipping pattern or isolated nocturnal hypertension is worth discussing with a hypertension specialist or nephrologist, especially if you have diabetes, chronic kidney disease, or sleep apnea.

If your result is low and you are on antihypertensive medication, ambulatory monitoring can reveal masked diastolic hypotension, which in one study of older treated hypertensives led to treatment reduction in about 30 percent of cases. Overtreatment is a real and underrecognized problem.

What Moves This Biomarker

Evidence-backed interventions that affect your 24h Avg Blood Pressure (Systolic) level

Decrease
Thiazide-type diuretics
A first-line treatment for elevated blood pressure. In the landmark ALLHAT trial, thiazide-type diuretics were superior in preventing major cardiovascular disease events compared to ACE inhibitors or calcium channel blockers. They lower blood pressure and have decades of outcome data showing reduced heart attacks, strokes, and heart failure at low cost.
MedicationStrong Evidence
Decrease
ACE inhibitors and angiotensin receptor blockers (ARBs)
Standard first-line options for lowering 24-hour systolic blood pressure, with proven reductions in cardiovascular events. ARBs show slightly fewer withdrawals for adverse effects than ACE inhibitors, with similar cardiovascular protection. Especially useful in people with diabetes or chronic kidney disease because they also protect kidney function.
MedicationStrong Evidence
Decrease
Calcium channel blockers
Reduce 24-hour systolic blood pressure and are often combined with ARBs for a more effective drop. In trials comparing combinations, losartan plus amlodipine (a calcium channel blocker) was superior to losartan plus hydrochlorothiazide for lowering 24-hour central blood pressure, particularly in men. Preferred first-step therapy after kidney transplantation.
MedicationStrong Evidence
Decrease
Sacubitril/valsartan
Switching from a standard ARB to sacubitril/valsartan reduced 24-hour systolic by about 7 mmHg in adults with advanced chronic kidney disease who were not reaching blood pressure goals. A useful option when single-agent therapy is not enough in kidney patients.
MedicationStrong Evidence
Decrease
DASH (Dietary Approaches to Stop Hypertension) diet
Consistently identified as the most effective non-pharmacologic intervention for lowering blood pressure across adults with prehypertension and established hypertension. Combined with reduced sodium, DASH lowers blood pressure across the full range of pre- and stage 1 hypertension, with the largest reductions at higher baseline pressures.
DietStrong Evidence
Decrease
Combined diet, exercise, and weight loss
The ENCORE trial showed the DASH diet alone, and especially combined with exercise and weight loss, meaningfully lowers blood pressure and improves cardiovascular biomarkers in overweight or obese adults. The DEW-IT trial showed a comprehensive lifestyle program can lower blood pressure even in adults already on antihypertensive medication.
LifestyleStrong Evidence
Decrease
SGLT2 inhibitors (such as empagliflozin) in diabetes
Primarily used for type 2 diabetes, but also lower 24-hour systolic blood pressure by about 3 to 5 mmHg on average, with diastolic reductions of 2 to 3 mmHg. In older adults with diabetes and uncontrolled nocturnal hypertension, empagliflozin reduced 24-hour systolic by about 7.7 mmHg versus placebo, independent of its glucose-lowering effect.
MedicationModerate Evidence
Decrease
Aerobic exercise training
A 12-week moderate-intensity aerobic exercise program reduced 24-hour and daytime ambulatory systolic blood pressure and improved cardiorespiratory fitness in adults with resistant hypertension. Meta-analyses of randomized trials confirm aerobic exercise reliably lowers ambulatory blood pressure in medicated hypertensive patients.
ExerciseModerate Evidence
Decrease
Sodium reduction
Reducing dietary sodium lowers blood pressure, especially when combined with the DASH diet. The blood pressure response is dose-dependent and larger in people with higher starting pressures. A cornerstone of guideline lifestyle advice for elevated blood pressure.
DietModerate Evidence
Decrease
Cannabidiol (CBD)
In a randomized, placebo-controlled crossover trial, chronic oral CBD reduced 24-hour mean systolic blood pressure by about 4 to 5 mmHg in adults with mild to moderate hypertension, with no serious adverse events. Evidence is still early and this is not a substitute for first-line therapy.
SupplementModerate Evidence
Increase
Acetaminophen daily use (4 grams per day)
Regular daily acetaminophen at 4 grams per day raised systolic blood pressure by about 5 mmHg in adults with hypertension in the PATH-BP randomized trial. This is not simply a lab artifact. The drug appears to genuinely raise vascular pressure, which over time would translate to higher cardiovascular risk.
MedicationModerate Evidence
Increase
Smoking
Smoking is a determinant of higher out-of-office blood pressure variability. Each cigarette also causes acute systolic spikes of 3 to 25 mmHg lasting minutes to hours. Chronic smoking contributes to arterial stiffness, which raises long-term 24-hour systolic pressure.
LifestyleModerate Evidence
Increase
Heavy alcohol intake
Acute alcohol shifts systolic blood pressure by anywhere from -24 to +24 mmHg depending on dose and timing. Regular heavy drinking raises chronic 24-hour blood pressure and interferes with antihypertensive medication. Moderate reduction can meaningfully lower readings.
LifestyleModerate Evidence
Decrease
GLP-1 receptor agonists
Lower systolic blood pressure modestly (about 2 to 3 mmHg on clinic or ambulatory measurement) across large trials in diabetes and obesity. Most of the effect is linked to weight loss rather than direct blood pressure action. One liraglutide trial found no change in 24-hour mean but higher evening systolic (+9 mmHg), showing time-of-day effects can vary.
MedicationModest Evidence
Decrease
Phentermine plus extended-release topiramate
Reduced 24-hour systolic blood pressure by about 3 mmHg versus placebo in adults with overweight or obesity. Most of the benefit likely comes from weight loss. A reasonable option if weight is the main driver of elevated pressure.
MedicationModest Evidence
Increase
NSAIDs (such as ibuprofen, naproxen, COX-2 inhibitors)
NSAIDs and COX-2 inhibitors raise systolic blood pressure by about 2.8 to 3.9 mmHg on average versus placebo in pooled analyses. The effect is meaningful if you take them frequently, and they may interfere with some blood pressure medications.
MedicationModest Evidence
Increase
SNRIs (such as venlafaxine) and other antidepressants
Serotonin-norepinephrine reuptake inhibitors (SNRIs) can raise systolic blood pressure, with the effect growing at higher doses. SSRIs generally have minimal effect but can occasionally cause orthostatic changes. If you are on one of these and your 24-hour reading is elevated, the medication may be contributing.
MedicationModest Evidence

Frequently Asked Questions

Panels containing 24h Avg Blood Pressure (Systolic)

24h Avg Blood Pressure (Systolic) is included in these pre-built panels.

References

32 studies
  1. Kikuya M, Hansen T, Thijs L, Björklund-bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-pedersen C, Lind L, Ibsen H, Imai Y, Staessen JCirculation2007
  2. Huang QF, Yang WY, Asayama K, Zhang Z, Thijs L, Li Y, O'brien E, Staessen JHypertension2021
  3. Staplin N, Sierra a, Ruilope L, Emberson J, Vinyoles E, Gorostidi M, Ruiz-hurtado G, Segura J, Baigent C, Williams BThe Lancet2023
  4. Yang WY, Melgarejo J, Thijs L, Zhang Z, Boggia J, Wei F, Hansen T, Asayama K, Ohkubo TJAMA2019